PE42998A1 - Derivados 1,25-dihidroxi-16,22,23-tridehidro-colecalciferol - Google Patents

Derivados 1,25-dihidroxi-16,22,23-tridehidro-colecalciferol

Info

Publication number
PE42998A1
PE42998A1 PE1997000190A PE00019097A PE42998A1 PE 42998 A1 PE42998 A1 PE 42998A1 PE 1997000190 A PE1997000190 A PE 1997000190A PE 00019097 A PE00019097 A PE 00019097A PE 42998 A1 PE42998 A1 PE 42998A1
Authority
PE
Peru
Prior art keywords
compounds
dihidroxi
colecalciferol
epimer
formula
Prior art date
Application number
PE1997000190A
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Jerome Anthony Iacobelli
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE42998A1 publication Critical patent/PE42998A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

SE REFIEREN A LOS COMPUESTOS DE FORMULA (I), EN DONDE: SI R1 ES CH2, ENTONCES R ES H, F o OH, PERO SI R1 ES H2, ENTONCES R ES HIDROXILO; SIENDO LOS COMPUESTOS PREFERIDOS, EL EPIMERO 22S Y EL EPIMERO 22R DEL 1,25-DIHIDROXI-16,22,23-TRIEN-COLECALCIFEROL. TAMBIEN SE REFIERE A LOS COMPUESTOS INTERMEDIOS SILILADOS Y AL PROCEDIMIENTO DE PREPARACION DE LOS COMPUESTOS DE FORMULA (I), QUE COMPRENDE LA ELIMINACION DE LOS GRUPOS PROTECTORES SILILO, Si(R4, R5 o R6), EN DONDE: R4 Y R6 SON ALQUILO INFERIOR Y R5 ES ALQUILO INFERIOR, ARILO o ARIL-ALQUILO INFERIOR, MEDIANTE LA REACCION CON UNA SAL DE FLUOR EN UN DISOLVENTE ORGANICO POLAR. LOS COMPUESTOS OBTENIDOS ACTUAN INHIBIENDO LA HIPERPROLIFERACION DE LA PIEL Y DE LAS CELULAS, SIENDO UTILES EN EL TRATAMIENTO DE TRANSTORNOS TALES COMO PSORIASIS, LEUCEMIA O ACNE, ENTRE OTROS
PE1997000190A 1996-03-21 1997-03-12 Derivados 1,25-dihidroxi-16,22,23-tridehidro-colecalciferol PE42998A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1380996P 1996-03-21 1996-03-21

Publications (1)

Publication Number Publication Date
PE42998A1 true PE42998A1 (es) 1998-08-11

Family

ID=21761865

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000190A PE42998A1 (es) 1996-03-21 1997-03-12 Derivados 1,25-dihidroxi-16,22,23-tridehidro-colecalciferol

Country Status (30)

Country Link
EP (1) EP0796843B1 (es)
JP (1) JP2801587B2 (es)
KR (1) KR100240541B1 (es)
CN (1) CN1110477C (es)
AR (1) AR006315A1 (es)
AT (1) ATE240941T1 (es)
AU (1) AU708679B2 (es)
BR (1) BR9701404A (es)
CA (1) CA2199893C (es)
CO (1) CO4820396A1 (es)
CZ (1) CZ85897A3 (es)
DE (1) DE69722064T2 (es)
DK (1) DK0796843T3 (es)
ES (1) ES2198512T3 (es)
HR (1) HRP970162A2 (es)
HU (1) HUP9700609A3 (es)
ID (1) ID16285A (es)
IL (1) IL120469A0 (es)
MA (1) MA26423A1 (es)
MX (1) MX9702139A (es)
NO (1) NO971217L (es)
NZ (1) NZ314424A (es)
PE (1) PE42998A1 (es)
PL (1) PL319070A1 (es)
PT (1) PT796843E (es)
SG (1) SG70589A1 (es)
TR (1) TR199700219A2 (es)
TW (1) TW444001B (es)
YU (1) YU10397A (es)
ZA (1) ZA972302B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
US6331642B1 (en) * 1999-07-12 2001-12-18 Hoffmann-La Roche Inc. Vitamin D3 analogs
KR101285720B1 (ko) * 2012-03-02 2013-07-19 주식회사 유니크메디케어 여드름 개선용 조성물
KR102493627B1 (ko) 2015-11-26 2023-01-31 코웨이 주식회사 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
DE69005897D1 (de) * 1989-05-18 1994-02-24 Hoffmann La Roche Dehydrocholecalciferolderivate.

Also Published As

Publication number Publication date
YU10397A (sh) 1999-07-28
EP0796843B1 (en) 2003-05-21
HUP9700609A3 (en) 1999-03-01
CN1110477C (zh) 2003-06-04
CZ85897A3 (cs) 1998-04-15
NZ314424A (en) 1998-07-28
MX9702139A (es) 1998-04-30
CN1172793A (zh) 1998-02-11
IL120469A0 (en) 1997-07-13
JP2801587B2 (ja) 1998-09-21
JPH107651A (ja) 1998-01-13
PL319070A1 (en) 1997-09-29
ATE240941T1 (de) 2003-06-15
HUP9700609A2 (hu) 1998-07-28
DE69722064D1 (de) 2003-06-26
KR100240541B1 (ko) 2000-01-15
CA2199893A1 (en) 1997-09-21
KR970065495A (ko) 1997-10-13
AU708679B2 (en) 1999-08-12
PT796843E (pt) 2003-09-30
DK0796843T3 (da) 2003-09-15
SG70589A1 (en) 2000-02-22
AU1513597A (en) 1997-09-25
EP0796843A3 (en) 1999-04-14
CO4820396A1 (es) 1999-07-28
BR9701404A (pt) 1998-11-03
TW444001B (en) 2001-07-01
MA26423A1 (fr) 2004-12-20
TR199700219A3 (tr) 1997-10-21
ID16285A (id) 1997-09-18
HRP970162A2 (en) 1998-04-30
DE69722064T2 (de) 2004-04-08
ZA972302B (en) 1997-09-22
CA2199893C (en) 2008-02-05
NO971217D0 (no) 1997-03-17
EP0796843A2 (en) 1997-09-24
NO971217L (no) 1997-09-22
TR199700219A2 (xx) 1997-10-21
HU9700609D0 (en) 1997-05-28
ES2198512T3 (es) 2004-02-01
AR006315A1 (es) 1999-08-25

Similar Documents

Publication Publication Date Title
ES2107559T3 (es) Procedimiento para la sintesis de silico-alumino-fosfatos microporosos cristalinos.
AR241474A1 (es) Preparacion de derivados de acido 3-aciltriciclo ¡5.2.1.0(2.6)¿-3-azadecan-4-carboxilico utiles como inhibidores de la enzima convertidora en angiotensina.
SE8304006D0 (sv) Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
PE120899A1 (es) Derivados de d-homo-9,10-seco-colesta-23-in-3,25-diol
FR2383605A1 (fr) Regulateurs de la croissance des vegetaux
PE20000267A1 (es) Derivados de ciclohexanodiol
PE42998A1 (es) Derivados 1,25-dihidroxi-16,22,23-tridehidro-colecalciferol
IT1165252B (it) Procedimento di purificazione dell'acido ursodesossicolico attraverso nuovi derivati
ES503800A0 (es) Procedimiento para la preparacion de peroxido de hidrogeno segun el procedimiento de antraquinona
ES2082894T3 (es) Dihidropirido(4,3-d)pirimidinas 4-sustituidas como analgesicos y agentes antiinflamatorios topicos para el tratamiento de enfermedades de la piel.
DK361383D0 (da) Substituerede 9-(1-0-eller 3-0--monosubstituerede eller 1,3-d1-o-substituerede propoxymethyl)-puriner og fremgangsmade til fremstilling deraf
EP0679152A1 (en) ANTIANDROGENE CYCLO AND BICYCLOALKENE.
PE26691A1 (es) Procedimiento de preparacion de azabencimidazoles, utiles en el tratamiento de asma, artritis y enfermedades relacionadas
BG50160A3 (en) Method for preparing of alcandiol dicarboxilates
MX3341E (es) Procedimiento para la preparacion de epoxi-androstanos
ATE9992T1 (de) 3-(buta-1',3'-dienyl)-substituierte derivate der cyclopropan-1-carbonsaeure, zusammensetzungen zur bekaempfung von pflanzenund warmblueterschaedlingen, sowie die parfuemierenden zusammensetzungen, die sie enthalten; ihre herstellung.
FR2384769A1 (fr) Triazoles bicycliques substitues utiles comme herbicides
SE7709317L (sv) Sett att framstella 2,9-dioxatricyklo(4,3,1,03,7)-dekaner
ATE77822T1 (de) 13alpha-alkylgonan-delta9(11)-5,10-epoxide.
GB653319A (en) Improvements in or relating to the manufacture of malonates and cyanoacetates
ATE177423T1 (de) Verfahren zur herstellung von provitamin-d- verbindungen
ES2028963T3 (es) Procedimiento para la obtencion de dien-1-oles, 9-hidroxidodec-10-enil-1-terc.-butileter y su empleo como producto intermedio para la sintesis de 8,10-dodecadienol.
ECSP972061A (es) Derivados de 1,25 -dihidroxi-16, 22, 23-trien - colecalciferol
SE9002713D0 (sv) Foerfarande foer framstaellning av vaeteperoxid och loesningsmedelsystem foer anvaendning vid denna framstaellning
ATE200T1 (de) Verfahren zur herstellung von alpha, beta-dihalogenalkylisocyanaten.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed